← Back to Patent Explorer
US4292965A Expired / Lapsed US ⏱️ 0.0 years remaining

Intravaginal ring

Assignee: Population Council
•
Filing: 1978-12-29
•
Granted: 1981-10-06
•
Expires: 1998-12-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to an improved intravaginal ring for use as a contraceptive comprising an inert elastomer core, a medicated layer encircling the core and an outer inert elastomer layer and method of manufacturing the intravaginal ring.

Inventors

  • 👤 Harold A. Nash
  • 👤 Daniel R. Mishell, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 23:23
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034; A61K9/0036; A61F; A61F6/00; A61F6/06; A61F6/08

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 79 words
A shell design intravaginal ring comprising in combination a core made of an inert elastomer, a medicated layer encircling the core, and an outer inert elastomer layer having a thickness of about 0.1 to 0.6 mm, the medicated layer comprising an inert elastomer and a combination of estradiol with a progestogen selected from the group consisting of levonorgestrel, d,l-norgestrel and norethindrone and the medicated layer having a thickness of not more than twice the thickness of the outer layer.
Claim 2
Dependent Claim 79 words
A shell design intravaginal ring comprising in combination a core made of an inert elastomer, a medicated layer encircling the core, and an outer inert elastomer layer having a thickness of about 0.1 to 0.6 mm, the medicated layer comprising an inert elastomer and a combination of estradiol with a progestogen selected from the group consisting of levonorgestrel, d,l-norgestrel and norethindrone and the medicated layer having a thickness of not more than twice the thickness of the outer layer.
Claim 3
Dependent Claim 21 words
The intravaginal ring described in claim 1 wherein the progesten is levonorgestrel and the outer layer is about 0.2 mm thick.
Claim 4
Dependent Claim 14 words
The intravaginal ring described in claim 1 wherein the inert elastomer is a polysiloxane.
Claim 5
Dependent Claim 37 words
The intravaginal ring as described in claim 1 wherein the inert elastomer is a polysiloxane, the medicated layer contains about 70 mg levonorgestrel and about 35 mg estradiol and the outer layer is about 0.2 mm thick.
Claim 6
Dependent Claim 22 words
The intravaginal ring as described in claim 4 wherein the medicated layer contains about 40-240 mg levonorgestrel and about 30-100 mg estradiol.
Claim 7
Dependent Claim 23 words
A method of contraception which comprises the steps of retainably positioning within the vaginal tract an intravaginal ring as defined in claim 1.
Claim 8
Dependent Claim 47 words
A method of contraception, which comprises the steps of retainably positioning within the vaginal tract an intravaginal ring as defined in claim 1 retaining the ring in place for an approximate three week period, and removing the ring for an approximate one week period to permit menstruation.
Claim 9
Independent Claim 130 words
A method of manufacturing a shell design intravaginal ring which consists of: (a) forming a core ring of a suitable inert elastomer; (b) dipping the core ring in a mixture of an inert volatile solvent containing an inert unvulcanized elastomer and a mixture of estradiol and a progestogen to form a medicated layer; (c) removing the ring from the mixture and allowing the solvent to evaporate; (d) repeating steps b and c until a medicated layer of the desired thickness is obtained; (e) dipping the ring from step d into a mixture of an inert unvulcanized elastomer in an inert volatile solvent removing the ring and allowing the solvent to evaporate to form an outer layer; and (f) repeating step e until an outer layer of desired thickness is obtained.
Claim 10
Independent Claim 130 words
A method of manufacturing a shell design intravaginal ring which consists of: (a) forming a core ring of a suitable inert elastomer; (b) dipping the core ring in a mixture of an inert volatile solvent containing an inert unvulcanized elastomer and a mixture of estradiol and a progestogen to form a medicated layer; (c) removing the ring from the mixture and allowing the solvent to evaporate; (d) repeating steps b and c until a medicated layer of the desired thickness is obtained; (e) dipping the ring from step d into a mixture of an inert unvulcanized elastomer in an inert volatile solvent removing the ring and allowing the solvent to evaporate to form an outer layer; and (f) repeating step e until an outer layer of desired thickness is obtained.
Claim 11
Dependent Claim 25 words
The method of manufacturing intravaginal rings as described in claim 1 wherein the progestogen is selected from the group consisting of levonorgestrel, d,l-norgestrel and norethindrone.
Claim 12
Independent Claim 201 words
A method of manufacturing a shell design intravaginal ring which consists of: (a) forming an annular core ring of a suitable inert elastomer by injecting the unvulcanized elastomer into a mold and allowing the ring to cure in the mold; (b) removing the core ring from the mold and cutting the ring open; (c) bringing the open ring to a constant weight; (d) pulling the open ring through a coating solution containing an unvulcanized elastomer and a mixture of estradiol and a progestogen; (e) dipping the coated open ring in a catalyst solution and allowing the coating to polymerize; (f) swelling a piece of tubing in volatile organic solvent and fitting it over the open ring from step e and allowing the solvent to evaporate; (g) trimming the excess tubing from the ends of the open ring and applying a medical grade adhesive to the ends of the open ring and on the surface of the ring close to the open end; (h) placing a piece of swollen tubing over both ends of the open ring to reform the ring and holding the ends of the open ring together for a few minutes and curing the ring for about 24 hours.
Claim 13
Independent Claim 201 words
A method of manufacturing a shell design intravaginal ring which consists of: (a) forming an annular core ring of a suitable inert elastomer by injecting the unvulcanized elastomer into a mold and allowing the ring to cure in the mold; (b) removing the core ring from the mold and cutting the ring open; (c) bringing the open ring to a constant weight; (d) pulling the open ring through a coating solution containing an unvulcanized elastomer and a mixture of estradiol and a progestogen; (e) dipping the coated open ring in a catalyst solution and allowing the coating to polymerize; (f) swelling a piece of tubing in volatile organic solvent and fitting it over the open ring from step e and allowing the solvent to evaporate; (g) trimming the excess tubing from the ends of the open ring and applying a medical grade adhesive to the ends of the open ring and on the surface of the ring close to the open end; (h) placing a piece of swollen tubing over both ends of the open ring to reform the ring and holding the ends of the open ring together for a few minutes and curing the ring for about 24 hours.
Claim 14
Dependent Claim 25 words
The method of manufacturing intravaginal rings as described in claim 10 wherein the progestogen is selected from the group consisting of levonorgestrel, d,l-norgestrel and norethindrone.
Claim 15
Independent Claim 189 words
A method of manufacturing a shell design intravaginal ring which consists of: (a) forming a core rod of suitable inert elastomer by injecting the unvulcanized elastomer into a mold and allowing it to cure: (b) removing the resulting core rod and cutting it into lengths about 15.5 cm; (c) bringing the rod to a constant weight; (d) pulling the rod through a coating solution containing a mixture of an unvulcanized elastomer and a mixture of estradiol and a progestogen; (e) dipping the coated rod in a catalyst solution and allowing the coating to polymerize; (f) swelling a piece of tubing in a volatile organic solvent, and sliding it over the coated rod from step e and allowing the solvent to evaporate; (g) trimming the excess tubing from the ends of the rod and applying a medical grade adhesive to the ends of the rod and to the surface of the rod close to the end; (h) placing a second piece of swollen tubing over both ends of the rod to form a ring and holding the ends of the rod together for 24 hours until the adhesive has cured.
Claim 16
Independent Claim 189 words
A method of manufacturing a shell design intravaginal ring which consists of: (a) forming a core rod of suitable inert elastomer by injecting the unvulcanized elastomer into a mold and allowing it to cure: (b) removing the resulting core rod and cutting it into lengths about 15.5 cm; (c) bringing the rod to a constant weight; (d) pulling the rod through a coating solution containing a mixture of an unvulcanized elastomer and a mixture of estradiol and a progestogen; (e) dipping the coated rod in a catalyst solution and allowing the coating to polymerize; (f) swelling a piece of tubing in a volatile organic solvent, and sliding it over the coated rod from step e and allowing the solvent to evaporate; (g) trimming the excess tubing from the ends of the rod and applying a medical grade adhesive to the ends of the rod and to the surface of the rod close to the end; (h) placing a second piece of swollen tubing over both ends of the rod to form a ring and holding the ends of the rod together for 24 hours until the adhesive has cured.
Claim 17
Dependent Claim 25 words
The method of manufacturing intravaginal rings as described in claim 12 wherein the progestogen is selected from the group consisting of levonorgestrel, d,l-norgestrel and norethindrone.

References Cited (Backward Citations)

US3545439A Cited
US3832252A Cited
US3920805A Cited
US4012497A Cited
US4012496A Cited
US4155991A Cited
US4096239A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-05 1985-04-06 1985-10-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-05 1989-04-06 1989-10-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-05 1993-04-06 1993-10-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag